Searchable abstracts of presentations at key conferences in endocrinology

ea0021p112 | Clinical practice/governance and case reports | SFEBES2009

Somatostatin analogues as an alternative treatment for type 1 gastric endocrine tumour: case report

Santos Ana P , Martins Raquel G , Couto Joana , Barbosa Ana P , Abreu Nuno , Leca Luis , Torres Isabel

Introduction: Gastric endocrine tumors (GET) are rare. Type 1 tumors are non-functioning, almost exclusively benign lesions, usually presenting as multiple polyps, usually <1 cm in diameter, which arise from gastric enterochromaffin-like cells in response to chronically elevated gastrin, secondary to (auto-immune) atrophic fundic gastritis. These tumors were traditionally treated with total gastrectomy, like adenocarcinomas. Currently, surveillance or endoscopic treatment ...